Targeted radiation aims to ease pain in advanced pancreatic cancer
NCT ID NCT05114213
First seen Dec 16, 2025 · Last updated May 07, 2026 · Updated 26 times
Summary
This study looked at whether adding MR-guided radiation to standard chemotherapy could reduce pain from the main tumor in people with metastatic pancreatic cancer. It enrolled 9 adults whose cancer had not worsened after 8 weeks of chemo. The trial was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospital of Heidelberg, Dep. of Radiation Oncology
Heidelberg, Germany
-
University Hospital of Zurich
Zurich, Switzerland
-
University of Munich, Dep. of Radiation Oncology
Munich, Bavaria, 81377, Germany
Conditions
Explore the condition pages connected to this study.